ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marc R. Moon
D. Craig Miller
Robert C. Robbins
Edward B. Stinson
Norman E. Shumway
Bruce A. Reitz
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moon, M. R.
Right arrow Articles by Reitz, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moon, M. R.
Right arrow Articles by Reitz, B. A.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2001;71:1164-1171
© 2001 The Society of Thoracic Surgeons


Original article: cardiovascular

Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis

Marc R. Moon, MDa, D. Craig Miller, MDa, Kathleen A. Moore, BSa, Phillip E. Oyer, MD, PhDa, R. Scott Mitchell, MDa, Robert C. Robbins, MDa, Edward B. Stinson, MDa, Norman E. Shumway, MDa, Bruce A. Reitz, MDa

a Department of Cardiovascular and Thoracic Surgery, Stanford University School of Medicine, Stanford, California, USA

Accepted for publication November 6, 2000.

Address reprint requests to Dr Miller, Department of Cardiovascular and Thoracic Surgery, Falk Cardiovascular Research Center, 300 Pasteur Dr, Stanford University School of Medicine, Stanford, CA 94305-5247
e-mail: dcm{at}leland.stanford.edu

Background. It remains unknown whether there is any important clinical advantage to the use of either a bioprosthetic or mechanical valve for patients with native or prosthetic valve endocarditis.

Methods. Between 1964 and 1995, 306 patients underwent valve replacement for left-sided native (209 patients) or prosthetic (97 patients) valve endocarditis. Mechanical valves were implanted in 65 patients, bioprostheses in 221 patients, and homografts in 20 patients.

Results. Operative mortality was 18 ± 2% and was independent of replacement valve type (p > 0.74). Long-term survival was superior for patients with native valve endocarditis (44 ± 5% at 20 years) compared with those with prosthetic valve endocarditis (16 ± 7% at 20 years) (p < 0.003). Survival was independent of valve type (p > 0.27). The long-term freedom from reoperation for patients who received a biologic valve who were younger than 60 years of age was low (51 ± 5% at 10 years, 19 ± 6% at 15 years). For patients older than 60 years, however, freedom from reoperation with a biological valve (84 ± 7% at 15 years) was similar to that for all patients with mechanical valves (74 ± 9% at 15 years) (p > 0.64).

Conclusions. Mechanical valves are most suitable for younger patients with native valve endocarditis; however, tissue valves are acceptable for patients greater than 60 years of age with native or prosthetic valve infections and for selected younger patients with prosthetic valve infections because of their limited life expectancy.




This article has been cited by other articles:


Home page
CirculationHome page
K. K. Stout and E. D. Verrier
Acute Valvular Regurgitation
Circulation, June 30, 2009; 119(25): 3232 - 3241.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. M. Fedoruk, W. R. E. Jamieson, H. Ling, J. S. MacNab, E. Germann, S. S. Karim, and S. V. Lichtenstein
Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis.
J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 326 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. M. Sheikh, A. M. Elhenawy, M. Maganti, S. Armstrong, T. E. David, and C. M. Feindel
Outcomes of surgical intervention for isolated active mitral valve endocarditis.
J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 110 - 116.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Okada, H. Tanaka, H. Takahashi, N. Morimoto, H. Munakata, M. Asano, M. Matsumori, Y. Kawanishi, K. Nakagiri, and Y. Okita
Aortic Root Replacement for Destructive Aortic Valve Endocarditis with Left Ventricular-Aortic Discontinuity
Ann. Thorac. Surg., March 1, 2008; 85(3): 940 - 945.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
T. E. David
Surgical Treatment of Aortic Valve Endocarditis
Card. Surg. Adult, January 1, 2008; 3(2008): 949 - 956.
[Full Text]


Home page
Card Surg AdultHome page
S. C. Stamou, G. Petterson, and A. M. Gillinov
Surgical Treatment of Mitral Valve Endocarditis
Card. Surg. Adult, January 1, 2008; 3(2008): 1069 - 1078.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
J.-F. Avierinos, F. Thuny, V. Chalvignac, R. Giorgi, L. Tafanelli, J.-P. Casalta, D. Raoult, T. Mesana, F. Collart, D. Metras, et al.
Surgical Treatment of Active Aortic Endocarditis: Homografts Are Not the Cornerstone of Outcome
Ann. Thorac. Surg., December 1, 2007; 84(6): 1935 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Colli, R. Campodonico, and T. Gherli
Early Switch From Vancomycin to Oral Linezolid for Treatment of Gram-Positive Heart Valve Endocarditis
Ann. Thorac. Surg., July 1, 2007; 84(1): 87 - 91.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Musci, H. Siniawski, M. Pasic, O. Grauhan, Y. Weng, R. Meyer, C. A. Yankah, and R. Hetzer
Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience
Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 118 - 125.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
L. de Kerchove, J.-L. Vanoverschelde, A. Poncelet, D. Glineur, J. Rubay, F. Zech, P. Noirhomme, and G. El Khoury
Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability
Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 592 - 599.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. H.H. Feringa, L. J. Shaw, D. Poldermans, S. Hoeks, E. E. van der Wall, R. A.E. Dion, and J. J. Bax
Mitral Valve Repair and Replacement in Endocarditis: A Systematic Review of Literature
Ann. Thorac. Surg., February 1, 2007; 83(2): 564 - 570.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Schmidtke, G. Dahmen, and H.-H. Sievers
Subcoronary Ross Procedure in Patients With Active Endocarditis
Ann. Thorac. Surg., January 1, 2007; 83(1): 36 - 39.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. E. David, G. Gavra, C. M. Feindel, T. Regesta, S. Armstrong, and M. D. Maganti
Surgical treatment of active infective endocarditis: A continued challenge
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 144 - 149.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Lima, G. C. Hughes, A. Lemaire, J. Jaggers, D. D. Glower, and W. G. Wolfe
Short-Term and Intermediate-Term Outcomes of Aortic Root Replacement with St. Jude Mechanical Conduits and Aortic Allografts
Ann. Thorac. Surg., August 1, 2006; 82(2): 579 - 585.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Mahesh, G. Angelini, M. Caputo, X. Y. Jin, and A. Bryan
Prosthetic Valve Endocarditis
Ann. Thorac. Surg., September 1, 2005; 80(3): 1151 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Siniawski, O. Grauhan, M. Hofmann, M. Pasic, Y. Weng, C. Yankah, H. Lehmkuhl, and R. Hetzer
Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment
Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 434 - 440.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Murashita, H. Sugiki, Y. Kamikubo, and K. Yasuda
Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes
Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1104 - 1111.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. G. Leyh, K. Knobloch, C. Hagl, A. Ruhparwar, S. Fischer, T. Kofidis, and A. Haverich
Replacement of the aortic root for acute prosthetic valve endocarditis: Prosthetic composite versus aortic allograft root replacement
J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1416 - 1420.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Lee and M. R. Moon
Homograft valve repair for recurrent prosthetic valve endocarditis
J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 725 - 727.
[Full Text] [PDF]


Home page
Card Surg AdultHome page
T. E. David
Surgical Treatment of Aortic Valve Endocarditis
Card. Surg. Adult, January 1, 2003; 2(2003): 857 - 866.
[Full Text]


Home page
Card Surg AdultHome page
F. Filsoufi and D. H. Adams
Surgical Treatment of Mitral Valve Endocarditis
Card. Surg. Adult, January 1, 2003; 2(2003): 987 - 997.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.